caffeic acid phenethyl ester has been researched along with n-vinyl-2-pyrrolidinone in 1 studies
Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (n-vinyl-2-pyrrolidinone) | Trials (n-vinyl-2-pyrrolidinone) | Recent Studies (post-2010) (n-vinyl-2-pyrrolidinone) |
---|---|---|---|---|---|
840 | 1 | 469 | 7,533 | 228 | 2,213 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ignatova, M; Manolova, N; Markova, N; Rashkov, I | 1 |
1 other study(ies) available for caffeic acid phenethyl ester and n-vinyl-2-pyrrolidinone
Article | Year |
---|---|
Antibacterial and antioxidant electrospun materials from poly(3-hydroxybutyrate) and polyvinylpyrrolidone containing caffeic acid phenethyl ester - "in" and "on" strategies for enhanced solubility.
Topics: Anti-Bacterial Agents; Antioxidants; Biphenyl Compounds; Caffeic Acids; Calorimetry, Differential Scanning; Crystallography, X-Ray; Dosage Forms; Drug Compounding; Escherichia coli; Hydroxybutyrates; Microscopy, Electron, Scanning; Phenylethyl Alcohol; Picrates; Polyesters; Povidone; Solubility; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Technology, Pharmaceutical | 2018 |